U.S. markets open in 4 hours 16 minutes

Emerald Health Therapeutics, Inc. (EMHTF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.0805-0.0016 (-1.92%)
At close: 3:52PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.0821
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0750 - 0.0853
52 Week Range0.0720 - 0.4660
Avg. Volume194,976
Market Cap17.172M
Beta (5Y Monthly)0.91
PE Ratio (TTM)N/A
EPS (TTM)-0.1410
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value

Subscribe to Yahoo Finance Plus to view Fair Value for EMHTF

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    Analyst Report: Curaleaf Holdings, Inc.Curaleaf is headquartered in Wakefield, Massachusetts, and cultivates and sells medicinal and recreational cannabis in the U.S. The company has operations in 23 states, including the assets from the Cura Select and Grassroots acquisitions. Its brands include Curaleaf, UKU, Select, and Grassroots. The company acquired EMMAC Life Sciences in March 2021, beginning its foray into the global medical market in competition with Canadian cannabis producers.
    Fair Value
    Economic Moat
    last monthMorningstar
View more
  • Newsfile

    Emerald Health Therapeutics Announces Chief Financial Officer Transition

    Vancouver, British Columbia--(Newsfile Corp. - September 10, 2021) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQX: EMHTF) ("Emerald") announced today that its Chief Financial Officer, Jenn Hepburn, will be stepping down from her position at Emerald, effective October 15, 2021, to pursue other interests. She will continue in her role until that time to help with transition-related activities."Jenn's effort has been pivotal in the implementation of strong financial systems and controls, and

  • Newsfile

    Emerald Health Therapeutics Reports 2021 Second Quarter Financial Results and Provides Corporate Update

    Vancouver, British Columbia--(Newsfile Corp. - August 31, 2021) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQX: EMHTF) ("Emerald") has released its financial results for the three and six months ended June 30, 2021. Full versions of Emerald's unaudited condensed interim consolidated financial statements and management discussion and analysis can be found on"In the second quarter we started to see incremental progress in executing on our renewed business strategy, resulting

  • Newsfile

    Emerald Health Therapeutics to Host 2021 Second Quarter Financial Results Conference Call on Tuesday, August 31, 2021 at 10:30 AM ET

    Vancouver, British Columbia--(Newsfile Corp. - August 25, 2021) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQX: EMHTF) ("Emerald") today announced that it will report its financial results for the second quarter ended June 30, 2021, after the market close on Monday, August 30, 2021. The company will host a conference call on Tuesday, August 31, 2021, at 10:30 a.m. ET.To access the audio broadcast, please dial (866) 652-5200, or via the internet at: